Dilip Kumar

Dilip Kumar has his PhD from Ludwig Maximillianâs University, Munich, Germany in the area of eukaryotic transcription regulation. After completion of PhD; he moved to Max Planck Institute of Biochemistry, Martinsried where he established BAC (Bacterial artificial chromosome) based mice transgenesis method. Currently, he is working in the field of functional genomics with an emphasis on allergy/Immune pathways in Chinese Singaporean population; he is trying to understand the underlying mechanisms for genetic regulation of immunological pathways in allergic diseases using transcriptomic, genetic, plasma biomarker, immune phenotyping and CAS9 based high-through put gene editing and homology directed recombination. Thousands of genetic pre-disposition markers for different diseases have been defined or are being defined, but most of these genetic markers are poorly understood. Such studies will be helpful to improve our understanding about the genetic predisposition towards specific human diseases, dysregulated biological pathways, and gene-drug interaction for better design of therapeutic intervention.